Atrial septal defect percutaneous closure benefits: Difference between revisions
No edit summary |
m (Robot: Changing Category:Disease state to Category:Disease) |
||
| Line 35: | Line 35: | ||
*[[Atrioventricular septal defect]] | *[[Atrioventricular septal defect]] | ||
*[[Congenital heart disease]] | *[[Congenital heart disease]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
| Line 40: | Line 42: | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Embryology]] | [[Category:Embryology]] | ||
[[Category:Disease | [[Category:Disease]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Overview complete]] | [[Category:Overview complete]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
Revision as of 19:15, 9 December 2011
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect percutaneous closure benefits On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect percutaneous closure benefits | |
|
Atrial septal defect percutaneous closure benefits in the news | |
|
Risk calculators and risk factors for Atrial septal defect percutaneous closure benefits | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
Among treatment options, percutaneous closure is the method of choice for ostium secundum patients. Many patients experience positive improvements in quality of life such as fewer complications, shorter hospital stays, and overall symptomatic improvement.
Benefits of percutaneous closure
The percutaneous closure of ostium secundum is the method of choice in many centers.[1], [2]. The benefits that can be associated with the closure are as follow:
Disease related benefits
- Fewer complications compared to surgical closure
- Reduced need for blood transfusions
- Symptomatic improvement
- Regression of positive airway pressure
- Positive changes in right ventricle performance
- Improved functional capacity [3]
- Improved left atrial volume index
- Improved left ventricular myocardial performance index
- Improved right ventricular myocardial performance index
- Improved peak oxygen uptake
Other benefits
- Less invasive no need for cardiopulmonary bypass
- Successful implantation rates of more than 96%.
- Established practice (done in most hospital these days)
- Cost-effective
- Shorter hospital stays
References
- ↑ Bjørnstad P (2006). "Is interventional closure the current treatment of choice for selected patients with deficient atrial septation?". Cardiol Young. 16 (1): 3–10. PMID 16454871.
- ↑ Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A (1999). "Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder". Heart. 82 (5): 559–62. PMC 1760778. PMID 10525508.
- ↑ Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC; et al. (2005). "Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects". J Am Coll Cardiol. 45 (4): 499–504. doi:10.1016/j.jacc.2004.10.052. PMID 15708694.